Increased formation of F(2)-isoprostanes in patients with severe heart failure.
Cracowski
J L
JL
Laboratory of Pharmacology LSCPA EA2937 Faculté de Médecine de Grenoble F-38706 La Tronche Cedex, France. Jean-Luc.Cracowski@ujf-grenoble.fr
Tremel
F
F
Marpeau
C
C
Baguet
J P
JP
Stanke-Labesque
F
F
Mallion
J M
JM
Bessard
G
G
D000328:Adult; D000368:Aged; D015415:Biomarkers / Q000652:urine; D016022:Case-Control Studies; D015232:Dinoprostone / Q000031:analogs & derivatives* / Q000652:urine; D005260:Female; D006333:Heart Failure / Q000652:urine*; D006801:Humans; D015227:Lipid Peroxidation; D008297:Male; D008875:Middle Aged; D012044:Regression Analysis
C108943:12-isoprostaglandin F(2alpha); D015415:Biomarkers; D015232:Dinoprostone